There is evidence for emergence of resistance in carried bacteria following antibiotic use in primary, secondary and tertiary care settings. And for example, the pneumococcal conjugate vaccine reduces the prevalence of resistant pneumococci in carriage.
Can community/population carriage of resistant bacteria predict the incidence of invasive disease by resistant bacteria?